China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.

Rapid advances in brain-computer interface technology are beginning to reshape modern healthcare, as hospitals and researchers expand clinical use of systems that allow patients with paralysis and ...

At the Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, a staff member processes invasive BCI flexible electrodes. (Photo provided by the Center for ...

What are brain-computer interfaces? Brain-computer interfaces (BCIs) are devices that allow for the action or control of an external device from brain signals. These technologies have a broad range of ...

An important milestone for brain-computer interfaces has been achieved. A new peer-reviewed neuroscience study led by researchers at the University of California, Los Angeles (UCLA) demonstrates a ...

Forbes contributors publish independent expert analyses and insights. Global Thought Leader in Cybersecurity and Emerging Tech Examining the mesh between humans and machines provides insight into the ...

Precision Neuroscience has obtained an FDA clearance for a crucial piece of its plans for a full brain-computer interface system, starting with its minimally invasive cortical electrode array. The ...

The rise of artificial intelligence (AI) deep learning algorithms is helping to accelerate brain-computer interfaces (BCIs). Published in this month’s Nature Neuroscience is new research that shows ...

The durability of communication with the use of brain–computer interfaces in persons with progressive neurodegenerative disease has not been extensively examined. We report on 7 years of independent ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to the Layer 7 Cortical Interface — a high-resolution cortical electrode array for use in recording, monitoring, and stimulating ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...